Artivion | CRY - Ingresos Por Ventas





Ventas Cambio Fecha
Abbott USD 11.16B 300M 2026-03
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 79.43M 3.72M 2025-09
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 141.2M 700K 2026-03
Baxter International USD 2.7B 270M 2026-03
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Inogen USD 74.93M 504K 2024-09
Integra LifeSciences USD 391.9M 43M 2026-03
J&J USD 24.1B 500M 2026-03
Mesa Laboratories USD 62.84M 5.01M 2024-12
Orthofix International USD 219.91M 14.28M 2025-12
Pfizer USD 14.5B 3.08B 2026-03
ResMed USD 1.4B 0 2026-03
Stryker USD 6B 1.2B 2026-03
Tandem Diabetes Care USD 247.22M 43.18M 2026-03
Teleflex USD 548.3M 20.68M 2026-03
Terumo JPY 300.32B 3.69B 2026-03
Trinity Biotech USD 14.31M 1.55M 2025-09